383 related articles for article (PubMed ID: 29463950)
1. Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial.
Messinis L; Nasios G; Kosmidis MH; Zampakis P; Malefaki S; Ntoskou K; Nousia A; Bakirtzis C; Grigoriadis N; Gourzis P; Papathanasopoulos P
Behav Neurol; 2017; 2017():5919841. PubMed ID: 29463950
[TBL] [Abstract][Full Text] [Related]
2. Computerized cognitive rehabilitation for treatment of cognitive impairment in multiple sclerosis: an explorative study.
Vilou I; Bakirtzis C; Artemiadis A; Ioannidis P; Papadimitriou M; Konstantinopoulou E; Aretouli E; Messinis L; Nasios G; Dardiotis E; Kosmidis M; Grigoriadis N
J Integr Neurosci; 2020 Jun; 19(2):341-347. PubMed ID: 32706198
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cognitive rehabilitation using computer software with individuals living with schizophrenia: A randomized controlled trial in Japan.
Iwata K; Matsuda Y; Sato S; Furukawa S; Watanabe Y; Hatsuse N; Ikebuchi E
Psychiatr Rehabil J; 2017 Mar; 40(1):4-11. PubMed ID: 28182471
[TBL] [Abstract][Full Text] [Related]
4. Functional and structural cerebral changes in key brain regions after a facilitation programme for episodic future thought in relapsing-remitting multiple sclerosis patients.
Ernst A; Sourty M; Roquet D; Noblet V; Gounot D; Blanc F; De Seze J; Manning L
Brain Cogn; 2016 Jun; 105():34-45. PubMed ID: 27045451
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
Hegedüs K; Kárpáti J; Iljicsov A; Simó M
Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of group cognitive rehabilitation therapy in multiple sclerosis.
Mani A; Chohedri E; Ravanfar P; Mowla A; Nikseresht A
Acta Neurol Scand; 2018 Jun; 137(6):589-597. PubMed ID: 29411360
[TBL] [Abstract][Full Text] [Related]
7. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis.
Mattioli F; Stampatori C; Zanotti D; Parrinello G; Capra R
J Neurol Sci; 2010 Jan; 288(1-2):101-5. PubMed ID: 19825502
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic effect of treatment with RehaCom software on verbal performance in patients with multiple sclerosis.
Arian Darestani A; Naeeni Davarani M; Hassani-Abharian P; Zarrindast MR; Nasehi M
J Clin Neurosci; 2020 Feb; 72():93-97. PubMed ID: 31937503
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia.
Peña J; Ibarretxe-Bilbao N; Sánchez P; Uriarte JJ; Elizagarate E; Gutierrez M; Ojeda N
J Psychiatr Res; 2018 Jun; 101():21-27. PubMed ID: 29525739
[TBL] [Abstract][Full Text] [Related]
11. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
13. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
14. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability.
Has Silemek AC; Fischer L; Pöttgen J; Penner IK; Engel AK; Heesen C; Gold SM; Stellmann JP
Neuroimage Clin; 2020; 25():102177. PubMed ID: 32014828
[TBL] [Abstract][Full Text] [Related]
15. Do Secondary Progressive Multiple Sclerosis patients benefit from Computer- based cognitive neurorehabilitation? A randomized sham controlled trial.
Messinis L; Kosmidis MH; Nasios G; Konitsiotis S; Ntoskou A; Bakirtzis C; Grigoriadis N; Patrikelis P; Panagiotopoulos E; Gourzis P; Malefaki S; Papathanasopoulos P
Mult Scler Relat Disord; 2020 Jan; 39():101932. PubMed ID: 31927200
[TBL] [Abstract][Full Text] [Related]
16. Moderators, mediators and nonspecific predictors of outcome after cognitive rehabilitation of executive functions in a randomised controlled trial.
Tornås S; Stubberud J; Solbakk AK; Evans J; Schanke AK; Løvstad M
Neuropsychol Rehabil; 2019 Jul; 29(6):844-865. PubMed ID: 28651477
[TBL] [Abstract][Full Text] [Related]
17. Integrative group-based cognitive rehabilitation efficacy in multiple sclerosis: a randomized clinical trial.
Rilo O; Peña J; Ojeda N; Rodríguez-Antigüedad A; Mendibe-Bilbao M; Gómez-Gastiasoro A; DeLuca J; Chiaravalloti N; Ibarretxe-Bilbao N
Disabil Rehabil; 2018 Jan; 40(2):208-216. PubMed ID: 27927036
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Planche V; Gibelin M; Cregut D; Pereira B; Clavelou P
Eur J Neurol; 2016 Feb; 23(2):282-9. PubMed ID: 25903918
[TBL] [Abstract][Full Text] [Related]
19. Combined exercise training improves cognitive functions in multiple sclerosis patients with cognitive impairment: A single-blinded randomized controlled trial.
Ozkul C; Guclu-Gunduz A; Eldemir K; Apaydin Y; Yazici G; Irkec C
Mult Scler Relat Disord; 2020 Oct; 45():102419. PubMed ID: 32736216
[TBL] [Abstract][Full Text] [Related]
20. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
